A novel machine learning model to predict high on-treatment platelet reactivity on clopidogrel in Asian patients after percutaneous coronary intervention

Evaluation of supervised machine learning algorithms in predicting the poor anticoagulation control and stable weekly doses of warfarin

(2022) Kannan Sridharan et al.   International Journal of Clinical Pharmacy

A study of the possible factors affecting COVID‐19 spread, severity and mortality and the effect of social distancing on these factors: Machine learning forecasting model

(2021) Hossam Zawbaa et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype

(2021) Daniel M.F. Claassens et al.   Circulation-Cardiovascular Interventions

Predicting Blood Concentration of Tacrolimus in Patients With Autoimmune Diseases Using Machine Learning Techniques Based on Real-World Evidence

(2021) Ping Zheng et al.   Frontiers in Pharmacology

Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel

(2020) Dominick J. Angiolillo et al.   JACC-Cardiovascular Interventions

Body weight, CYP2C19, and P2Y12 receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance

(2020) Zhiqiang Li et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared to Ticagrelor in PCI-Treated ACS Patients

(2020) Mina W. Mohareb et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial

(2020) Dagmar F Hernandez-Suarez et al.   BMJ Open

Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention

(2020) Yuichi Saito et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial

(2019) Dániel Aradi et al.   EUROPEAN HEART JOURNAL

Association Between Residual Platelet Reactivity on Clopidogrel Treatment and Severity of Coronary Atherosclerosis: Intrinsic Hypercoagulability as a Mediator

(2019) Xin Zhao et al.   ADVANCES IN THERAPY

Tailored P2Y12 inhibitor treatment in patients undergoing non-urgent PCI—the POPular Risk Score study

(2019) Paul W. A. Janssen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

(2019) Dirk Sibbing et al.   JACC-Cardiovascular Interventions

Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)

(2019) Björn Redfors et al.   AMERICAN JOURNAL OF CARDIOLOGY

Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients

(2019) Mohammed El Haouari   CURRENT MEDICINAL CHEMISTRY

Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry

(2019) Subhi J Al’Aref et al.   EUROPEAN HEART JOURNAL

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention

(2018) Larisa H. Cavallari et al.   Journal of Translational Medicine

Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study

(2018) Hyung Joon Joo et al.   Scientific Reports

Platelet monitoring for PCI

(2018) D. Capodanno et al.   Hamostaseologie

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis

(2018) Dong Wang et al.   BMC Cardiovascular Disorders

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

(2017) Marco Valgimigli et al.   EUROPEAN HEART JOURNAL

Trends in P2Y12 Inhibitor Use in Patients Referred for Invasive Evaluation of Coronary Artery Disease in Contemporary US Practice

(2016) Weihong Fan et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effects of Concurrent Calcium Channel Blocker on Antiplatelet Efficacy of Clopidogrel Therapy

(2016) Saurabh Aggarwal et al.   AMERICAN JOURNAL OF THERAPEUTICS

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

(2016) Glenn N. Levine et al.   CIRCULATION

Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

(2015) Xi-Ling Jiang et al.   CLINICAL PHARMACOKINETICS

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

(2015) Dániel Aradi et al.   EUROPEAN HEART JOURNAL

Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy

(2015) Vladimir Ignjatovic et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Genetic and non-genetic factors responsible for antiplatelet effects of clopidogrel in Japanese patients undergoing coronary stent implantation: An algorithm to predict on-clopidogrel platelet reactivity

(2014) Go Miura et al.   THROMBOSIS RESEARCH

Relationship Between ABCB1 Polymorphisms, Thromboelastography and Risk of Bleeding Events in Clopidogrel-Treated Patients With ST-Elevation Myocardial Infarction

(2014) Jia-Hui Zhang et al.   THROMBOSIS RESEARCH

Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

(2013) Udaya S. Tantry et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

(2013) Gregg W Stone et al.   LANCET

Genetic Polymorphisms and Drug Interactions Leading to Clopidogrel Resistance: Why the Asian Population Requires Special Attention

(2012) Md. Shariful Hasan et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention

(2011) Matthew J. Price et al.   CIRCULATION

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

(2011) R. C. Becker et al.   EUROPEAN HEART JOURNAL

Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

(2009) Stefan James et al.   AMERICAN HEART JOURNAL

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic Determinants of Response to Clopidogrel and Cardiovascular Events

(2008) Tabassome Simon et al.   NEW ENGLAND JOURNAL OF MEDICINE